By: J. Collins PhD
The annual World Conference on Lung Cancer (WCLC) once again brought together the latest information for the field of lung cancer in September 2024. Research into non-small cell lung cancer (NSCLC) was of special interest at this meeting, with various treatment regimens having being trialled. Here, some of the highlights of NSCLC from this meeting are summarised.
(BELG J MED ONCOL 2024;18(7):282–286)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
